|
Nobuhisa Hagiwara
Department Other, Other Position |
|
| Article types | Original article |
| Language | English |
| Peer review | Peer reviewed |
| Title | Long-Term Safety and Efficacy of Platinum Chromium Everolimus-Eluting Stents in Coronary Artery Disease: 5-Year Results From the PLATINUM Trial. |
| Journal | Formal name：JACC. Cardiovascular interventions Abbreviation：JACC Cardiovasc Interv ISSN code：1936-8798/1876-7605 |
| Domestic / Foregin | Foregin |
| Publisher | Elsevier |
| Volume, Issue, Page | 10(23),pp.2392-2400 |
| Author and coauthor | Kelly Christopher R, Teirstein Paul S, Meredith Ian T, Farah Bruno, Dubois Christophe L, Feldman Robert L, Dens Joseph, Hagiwara Nobuhisa, Rabinowitz Abram, Carrié Didier, Pompili Vincent, Bouchard Alain, Saito Shigeru, Allocco Dominic J, Dawkins Keith D, Stone Gregg W |
| Publication date | 2017/12 |
| Summary | PtCr-EES demonstrated comparable safety and effectiveness to CoCr-EES through 5 years of follow-up, with low rates of stent thrombosis and other adverse events. The 5-year event rates were also acceptable in patients with small vessels and long lesions treated with PtCr-EES. (The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions [PLATINUM]; NCT00823212; The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of De Novo Coronary Artery Lesions in Small Vessels [PLATINUM SV]; NCT01498692; The PLATINUM Clinical Trial to Assess the PROMUS Element Stent System for Treatment of Long De Novo Coronary Artery Lesions [PLATINUM LL]; NCT01500434). |
| DOI | 10.1016/j.jcin.2017.06.070 |
| PMID | 29217001 |